Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), Malaga, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Institute of Health Carlos III, Madrid, Spain.
Am J Clin Nutr. 2020 May 1;111(5):975-982. doi: 10.1093/ajcn/nqaa064.
Many food items included in the Mediterranean diet (MedDiet) are rich in polyamines, small aliphatic amines with potential cardioprotective effects. The consumption of a MedDiet could increase polyamine concentrations. Based on experimental models, polyamine concentrations may be also influenced by physical activity (PA).
We aimed to evaluate whether an intervention based on an energy-restricted MedDiet (er-MedDiet) and PA promotion, in comparison with an energy-unrestricted MedDiet and traditional health care, influences the serum pattern of polyamines and related metabolites in subjects at high risk of cardiovascular disease (CVD).
This was a substudy from the PREDIMED-Plus trial, an ongoing randomized clinical trial including 6874 participants allocated either to an intensive weight-loss lifestyle intervention based on er-MedDiet, PA promotion, and behavioral support (er-MedDiet + PA group), or to an energy-unrestricted MedDiet and traditional health care group (MedDiet group). A total of 75 patients (n = 38, er-MedDiet + PA group; n = 37, MedDiet group) were included in this study. Serum concentrations of arginine, ornithine, polyamines, and acetyl polyamines at baseline and 26 wk of intervention were measured by an ultra-high-performance LC-tandem MS platform.
At week 26, study groups had similar adherence to the MedDiet but patients randomly assigned to the er-MedDiet + PA group showed significantly lower mean energy intake (-340.3 kcal/d; 95% CI: -567.3, -113.4 kcal/d; P = 0.004), higher mean PA (1290.6; 95% CI: 39.9, 2541.3 metabolic equivalent tasks · min/d; P = 0.043), and higher mean decrease in BMI (in kg/m2) (-1.3; 95% CI: -1.8, -0.6; P < 0.001) than the MedDiet group. However, no significant differences in serum polyamines or related metabolites were found between study groups after 26 wk of intervention and no significant between-group differences were found in glycated hemoglobin, HDL-cholesterol, or triglyceride concentrations.
In individuals at high CVD risk, an er-MedDiet with increased PA did not result in significant changes of serum concentrations of polyamines or related metabolites in comparison with an energy-unrestricted MedDiet and no increase in PA. This trial was registered at isrctn.com as ISRCTN89898870.
地中海饮食(MedDiet)中包含的许多食物都富含多胺,多胺是一种具有潜在心脏保护作用的小型脂肪族胺类物质。多胺浓度可能会随着 MedDiet 的摄入而增加。基于实验模型,多胺浓度也可能受到体力活动(PA)的影响。
我们旨在评估与能量不受限制的 MedDiet 和传统保健相比,基于能量限制的 MedDiet(er-MedDiet)和 PA 促进的干预措施是否会影响心血管疾病(CVD)高危人群的血清多胺和相关代谢物模式。
这是 PREDIMED-Plus 试验的一项子研究,这是一项正在进行的随机临床试验,包括 6874 名参与者,他们被分配到基于 er-MedDiet、PA 促进和行为支持的强化减肥生活方式干预组(er-MedDiet + PA 组)或能量不受限制的 MedDiet 和传统保健组(MedDiet 组)。本研究共纳入 75 例患者(n = 38,er-MedDiet + PA 组;n = 37,MedDiet 组)。采用超高效 LC-串联 MS 平台检测基线和干预 26 周时血清中精氨酸、鸟氨酸、多胺和乙酰多胺的浓度。
在第 26 周时,两组对 MedDiet 的依从性相似,但随机分配到 er-MedDiet + PA 组的患者的平均能量摄入明显降低(-340.3 kcal/d;95%CI:-567.3,-113.4 kcal/d;P = 0.004),PA 平均值更高(1290.6;95%CI:39.9,2541.3 代谢当量·min/d;P = 0.043),体重指数(BMI)平均降低(kg/m2)(-1.3;95%CI:-1.8,-0.6;P < 0.001)高于 MedDiet 组。然而,干预 26 周后,两组间血清多胺或相关代谢物无显著差异,糖化血红蛋白、高密度脂蛋白胆固醇或甘油三酯浓度无组间差异。
在 CVD 风险较高的个体中,与能量不受限制的 MedDiet 相比,增加 PA 的 er-MedDiet 并未导致血清多胺或相关代谢物浓度发生显著变化,并且 PA 也没有增加。这项试验在 isrctn.com 注册为 ISRCTN89898870。